Loading...

Archive

    06 August 2021, Volume 36 Issue 8 Previous Issue    Next Issue

    For Selected: Toggle Thumbnails
    Expert consensus on the treatment of childhood rhinitis with Biyuan Tongqiao Granules
    2021, 36(8): 561-564.  DOI: 10.19538/j.ek2021080601
    Abstract ( )  
    Interpretation of Expert Consensus on the Diagnosis and Management of Growth Hormone Deficiency during the Transition Period
    WU Wei,LUO Xiao-ping
    2021, 36(8): 565-569.  DOI: 10.19538/j.ek2021080602
    Abstract ( )  
    With the attention of pediatric clinicians to the reassessment,diagnosis,and treatment of transitional growth hormone deficiency(TGHD),and the latest research results and published guidelines abroad,the Subspecialty Group of Endocrinologic,Hereditary and Metabolic Diseases,the Society of Pediatrics,the Chinese Medical Association issued Expert on the Diagnosis and Management of Growth Hormone Deficiency during the Transition Period(hereinafter referred to as "the consensus"). The consensus emphasizes the role of continuing treatment in transitional patients,introduces the most challenging topics: when and how to retest;which diagnostic tests are best suited;how to adjust the dose of rhGH;how to monitor rhGH replacement therapy;how safe is rhGH replacement therapy. The paper makes a general introduction and a brief interpretation about the consensus content,and combines with the actual situation of our country for further discussion.
    Normal growth laws and regulation mechanism of children
    HUANG Ke, FU Jun-fen
    2021, 36(8): 570-573.  DOI: 10.19538/j.ek2021080603
    Abstract ( )  
    Growth is a continuous non-linear process,and the regulation mechanism and growth characteristics in different periods are different. The growth of bones is affected by many factors,and the cartilage growth plate is the key to bone growth and development. Various regulatory mechanisms,including nutrition,endocrine hormones,inflammatory cytokines,paracrine signals,extracellular matrix,etc.,play a role in the growth of bones by regulating the maturation and differentiation of growth plate chondrocytes. Mastering the normal growth laws and regulation mechanisms is extremely important for the diagnosis,differential diagnosis,and standardized treatment of children with short stature.
    Signaling pathway and circadian clock of growth plate affecting chondrocyte activities of growth plate
    SUI Sheng-bin,GONG Chun-xiu
    2021, 36(8): 573-581.  DOI: 10.19538/j.ek2021080604
    Abstract ( )  
    The bone growth of human body is achieved mainly through two ways,intramembranous ossification and endochondral ossification,the endochondral ossification process on the growth plate is the main mechanism of growth. Growth plate is a columnar structure at the end of epiphysis,which consists of chondrocytes and extracellular matrix(ECM) secreted from chondrocytes. Chondrocyte is the unique cell type on the growth plate,therefore almost all of the endocrine factors and transcriptional regulation factors are functioning by regulating the activity of chondrocytes. So,this essay will introduce some signaling pathways that regulate ossification through affecting the chondrocytes of growth plate and circadian clock of the growth plate.
    A hormonal approach to the evaluation of short stature
    XI Li, LUO Fei-hong
    2021, 36(8): 581-585.  DOI: 10.19538/j.ek2021080605
    Abstract ( )  
    Short stature and insufficient height growth are increasingly concerned by society,parents,and pediatricians. While the demands for increasing height are ever increasing,the biggest challenge is to correctly distinguish between normal variations and abnormal forms of children’s growth through the selection of appropriate methods so as to be clear about the cause of short stature and choose the correct intervention measures. This article reviews the short stature during childhood from an endocrinological aspect.
    View on short stature from the perspective of growth plate 
    MA Hua-mei
    2021, 36(8): 585-591.  DOI: 10.19538/j.ek2021080606
    Abstract ( )  
    The growth plate is the target organ of linear growth. Short stature reflects the growth disorders of long bone. The genetic defect that impairs growth plate chondrogenesis may cause linear growth disorders,which leads to short stature. The mechanism of locally regulating growth of growth plate includes extracellular matrix,intracellular signaling pathway,and paracrine signaling pathway. The genes mutation causing short stature is of high heterogeneity and pleiotropy,that is,the phenotype is of broad spectrum,from simple isolated short stature to syndromatic one. Rapid progress in Next Generation Sequencing(NGS) allows identification of more and more genes affecting chondrogenesis at the growth plate leading to growth disorders and short stature,which will improve our knowledge and diagnosis of short stature.
    GH-IGF-I axis signaling pathway and paracrine signaling pathways in the pathogenesis of growth disorder
    CHENG Xin-ran,LENG Jie
    2021, 36(8): 592-597.  DOI: 10.19538/j.ek2021080607
    Abstract ( )  
    For many years,growth hormone(GH) has been known to be the primary hormone responsible for body growth.GH also regulates carbohydrate,protein and lipid metabolism. Human genetic defects affecting the GH-insulin-like growth factor(IGF)-I axis of the IGF system present with growth failure as their principal clinical feature. GH promotes postnatal human growth primarily by regulating IGF-I production through activation of the GH receptor (GHR)-JAK2-signal transducer and activator of transcription (STAT)-5B signaling pathway. Many other pathways are activated by the GHR-JAK2 system,including the ERK1,2(extracellular signal regulated kinases,ERK) pathway and the PI3K(phosphoinositide-3 kinase) pathways. Modulating elements,including the SOCS proteins,phosphatases,and GHR metalloproteinase,also play a role in growth failure. GHR-JAK2-STST-5B is a classical pathway,and EKRs and IRS-PI3K are the main bypass pathways.
    Growth hormone deficiency and nonalcoholic fatty liver disease
    QIN Miao,GONG Chun-xiu
    2021, 36(8): 597-602.  DOI: 10.19538/j.ek2021080608
    Abstract ( )  
    In addition to its growth promoting role,growth hormone(GH) has a significant effect on intermediary metabolism in the healthy state. Pediatric practitioners usually focus on the growth promoting aspects of GH but overlook the effect on metabolism. In recent years,the clinical reports on various animal and human studies(in adults mainly) have repeatedly shown the association of GH deficiency(GHD) with fatty liver disease. Despite a lack of studies involving children,the pediatric clinician should ensure that not only patients with GHD are appropriately treated but adolescents even beyond the period of linear growth should be given appropriate GH therapy to ensure the transition to adulthood.
    Research progress in small for gestational age
    YOU Jing-yu,SU Zhe,PAN Li-li
    2021, 36(8): 602-607.  DOI: 10.19538/j.ek2021080609
    Abstract ( )  
    The incidence of small for gestational age(SGA) is not low in China. The pathogenesis is complex,including placental,maternal and fetal factors. The fetal factors are getting more and more attention,especially genetic etiologies. Managements of SGA include catch-up growth and prevention and treatment of short- and long-term complications of multiple systems. Appropriate catch-up growth is important. The contraindications of growth hormones should be kept in the mind of clinical doctors. Complications of multiple systems include neural development and cognition impairments,cardiovascular and metabolic disorders,pubertal development and fertility issues. Because of similar growth risks,intrauterine and extrauterine growth retardation(IUGR/EUGR) deserves equal attention of clinical doctors.
    Benefits and risks of growth hormone therapy based on evidence-based medicine
    WEI Hai-yan
    2021, 36(8): 607-612.  DOI: 10.19538/j.ek2021080610
    Abstract ( )  
    Since the recombinant human growth hormone(rhGH) was launched in 1985,it has been used to treat millions of children with short stature,and its indications have continued to expand. However,the phenomenon of off-label use and the use solely for increasing height is becoming more and more serious. Because of this,many academic groups have issued guidelines or consensus,hoping to standardize the application of rhGH. The final height benefit of rhGH treatment for GHD is the greatest. In other non-GHD diseases,including idiopathic short stature,Turner syndrome,etc.,the application of rhGH to promote growth has limited benefits. The safety of long-term use of rhGH is still controversial. Clinicians should be cautious when prescribing rhGH and use it in a standardized manner.
    Ovarian function assessment and hormone replacement therapy in Turner syndrome
    ZHU Min
    2021, 36(8): 613-616.  DOI: 10.19538/j.ek2021080611
    Abstract ( )  
    Turner syndrome is usually accompanied by hypergonadotropic hypogonadism and primary or secondary amenorrhea. Most TS individuals will therefore need hormonal replacement therapy(HRT) for induction of puberty and later for maintaining secondary sex characteristics,attaining peak bone mass,normalizing uterine growth. The goals of hormone replacement are to mimic the normal physical and social development. The optimal hormone replacement treatment regimen to induce pubertal development is still being determined and improved. Treatment should begin at 11-12 years of age,with dose increasing every 6 months over a 2-3-year period. Initiation of puberty with low doses of estrogen is crucial to preserve growth potential. This paper discusses the sex steroid replacement therapy in younger patients with Turner syndrome,aiming to provide practical help for clinicians.
    Assessment of multiple polymerase chain reaction in detecting pathogens of children hospitalized with pneumonia:A preliminary study
    WANG Gui-qing,DONG Xiao-yan,ZHONG Hai-qin,et al
    2021, 36(8): 617-622.  DOI: 10.19538/j.ek2021080612
    Abstract ( )  
    Objective To understand the distribution of pathogens in hospitalized children with pneumonia,and to investigate the clinical value of multiple polymerase chain reaction(mPCR). Methods A total of 230 children who were hospitalized for pneumonia in Shanghai Children’s Hospital from September 2019 to June 2020 were prospectively enrolled. Both mPCR and routine microbiological methods were performed in children. Nasopharyngeal and oropharyngeal(NP-OP) specimens were tested with mPCR which could detect 35 kinds of respiratory pathogen at the same time. Sputum specimens were tested with routine microbiological methods(culture and direct immunofluorescence assay) which could detect bacteria,fungus and 8 kinds of respiratory virus. Blood specimens were tested with routine microbiological methods(particle agglutination)which could detect Mycoplasma pneumoniae antibody. Results We enrolled 230 cases,136(59.1%) boys and 94(40.9%) girls,and the median age of the patients was (3.6±3.0) years old. The top 10 pathogens detected by mPCR  were Streptococcus pneumoniae(17%),human adenovirus(13.9%),Mycoplasma pneumoniae(13.9%),human rhinovirus(10.0%),cytomegalovirus(10.0%) ,human respiratory syncytial virus(9.6%),human coronavirus(9.6%),human bocavirus(8.3%),human metapneumovirus(7.4%) and Escherichia coli(6.1%). Cytomegalovirus and  Escherichia coli were more common among children younger than 3 years of age than among the children at and over 3 years old[(19.8% vs. 0,χ2=25.115,P=0.000),(10.3% vs. 1.8%,χ2=7.422,P=0.006)],while Mycoplasma pneumoniae was less common among children younger than 3 years of age detected by mPCR(5.2% vs. 22.8%,χ2=14.928,P=0.000). The detection rate of one or more pathogens,two or more pathogens,viral pathogens,bacterial and fungus pathogens using mPCR were significantly higer than that using routine microbiological methods[(78.7% vs. 65.2%,χ2=10.353,P=0.001),(49.1% vs. 11.7%,χ2=75.941,P=0.000),(58.7% vs. 8.3%,χ2=131.350,P=0.000),(43.5% vs. 17.4%,χ2=36.964,P=0.000),(3.5% vs. 0.4%,χ2=4.080,P=0.043)];however,the detection rate of Mycoplasm pneumoniae using mPCR was significantly lower than that using routine microbiological methods(13.9% vs. 50.0%,χ2=68.874,P=0.000). The consistency of the same pathogen detection between mPCR and routine microbiological methods was not good(Kappa<0.5,P<0.05). Conclusion The most common pathogens are various viruses and bacteria in hospitalized children with pneumonia in Shanghai Children’s Hospital and nearly half of all cases had two or more pathogens detected. Compared with the routine microbiological method,mPCR is helpful in early identification of pneumonia pathogen in children.
    Clinical analysis of drugs combined with nasal secretion suction in the treatment of adenoid hypertrophy of grade Ⅲ
    XU Yang-yang,LIN Zong-tong,LIN Xing,et al
    2021, 36(8): 623-628.  DOI: 10.19538/j.ek2021080613
    Abstract ( )  
    Objective To investigate the short-term and long-term efficacy of intranasal steroids and oral montelukast combined with nasal secretion suction in the treatment for children with adenoid hypertrophy of grade Ⅲ. Methods A total of 132 children with adenoid hypertrophy of grade Ⅲ by electron-nasopharyngolaryngoscope from June 2017 to December 2019 were enrolled. They were divided into group A(3-6 years old) and group B(7-14 years old) by age and each group was randomly divided into two subgroups:A1 and B1 groups(treatment groups) were treated with intranasal steroids and oral montelukast combined with nasal secretion suction,while A2 and B2 groups(control groups) were only treated with intranasal steroids combined with oral montelukast. VAS symptom score and electronic nasopharyngoscopy were used to make asessments before treatment,3 months and 12 months after treatment. Results The comparison of efficacy between the treatment groups and the control groups: in terms of VAS symptom score and adenoid size change,at 3 and 12 months after treatment,group A1 was better than group A2 and group B1 was better than group B2(P<0.05). The comparison of efficacy between younger groups and older groups:in terms of VAS symptom score,at 3 months after treatment,there was no significant difference between group A1 and group B1(P>0.05),but at 12 months after treatment group B1 was better than group A1(P<0.05),while group B2 was better than group A2 at 3 months and 12 months after treatment(P<0.05);in terms of adenoid size change,at 3 months after treatment,there was no significant difference between group A1 and group B1 or between group A2 and group B2(P>0.05),but after 12 months of treatment,group B1 was better than group A1,and group B2 was better than group A2(P<0.05). Conclusion Intranasal steroids and oral montelukast combined with nasal secretion suction in the treatment of children with adenoid hypertrophy of grade Ⅲ has a significant short-term efficacy,but the long-term efficacy varies by age,which is significant in children at 7-14 years old,reducing the need for surgery. The disease is likely to relapse in the children aged 3 to 6 years,and the adenoid hypertrophy keeps getting severe,so it is suggested to perform surgery,or it can be as a temporary treatment for children with operative contraindications.
    Clinical and laboratory features of acute benign myositis associated with Mycoplasma pneumoniae infection in children
    HE Li,ZHANG Qian-zhong
    2021, 36(8): 629-631.  DOI: 10.19538/j.ek2021080614
    Abstract ( )  
    Objective To investigate the clinical and laboratory features of acute benign myositis associated with Mycoplasma pneumoniae  infection in children. Methods We conducted a retrospective analysis on the data of 12 cases of acute benign myositis related to Mycoplasma pneumoniae infection in children in the First Hospital of China Medical University. Results 1.The most common symptom was sudden leg pain in the course of respiratory tract infection and bilateral lower leg myodynia was more common. The most common and prominent sign is calf pain and gastrocnemius grip. 2.The values of 12 cases of creatine kinase(CK) were (645-18 990) μg/L(mean 3697 μg/L),greater than twice the upper limit of reference interval,with 11 cases>1000 μg/L and 2 cases>5000 μg/L. The results of serum myoglobin(Mb) in 7 cases were (137.6-872.0) μg/L (mean 474.8 μg/L),with 6 cases greater than twice the upper limit of reference interval. From the dynamic changes of the detection value,CK decreased to normal range within one week,and Mb decreased to normal range within 5 days,slightly faster than CK. 3.The titer of MP-Ab of 12 cases was greater than 1∶160,including 6 cases of 1∶320,12 cases of IgM positive and 9 cases of IgG positive. The detection values of troponin I in 10 cases were (0.00-0.04) μg/L,with no increase. Conclusion 1.Mycoplasma pneumoniae antibody should be routinely examined in children with acute benign myositis. 2.In the case of diagnosing or suspecting BACM,serum CK and Mb should be detected simultaneously and their changes should be observed dynamically. 3.BACM children with Mycoplasma pneumoniae infection should be treated with macrolide antibiotics in addition to bed rest and less physical activity. The need for myocardial metabolism activating drugs and hydration alkalization is judged according to serum troponin Ⅰ,electrocardiogram,urine occult blood test,etc.
    Current situation of functional gastrointestinal disease in the pediatric gastrointestinal clinic: A clinical report from single center
    ZOU Yi,ZHANG Hui-hua,LIU Bo,et al
    2021, 36(8): 632-636.  DOI: 10.19538/j.ek2021080615
    Abstract ( )  
    Objective To understand the current situation of functional gastrointestinal diseases(FGIDs) in pediatric digestive clinic,and to strengthen the cognition of FGIDs in children. Methods The clinical data of patients aged 0 to 18 years old in Department of Gastroenterology,Children’s Hospital of Chongqing Medical University between June 2016 and December 2019 were retrospectively analyzed by utilizing FGIDs ROME Ⅳ criteria. Results A total of 11 810 patients were enrolled in pediatric digestive clinic and 2788(23.61%) were FGIDs patients. The percentage of FGIDs was 19.48%(1664/8541) in the neonate/toddlers group and 34.38%(1124/3269) in the children/adolescent group. The percentage of FGIDs in children/adolescents group was significantly higher than that in neonate/toddlers group(χ2=291.08,P<0.01). The percentage of FGIDs was higher in female than in male(P<0.01) in neonate/toddlers group(χ2=24.19),children/adolescents group(χ2=12.64) and the total patients in pediatric digestive clinic(χ2=28.86). The most common type of FGIDs in neonate/toddlers was functional constipation(49.04%),followed by infant dyschezia(22.96%),infant regurgitation(14.00%),functional diarrhea(10.76%) and infant colic(2.58%). Cyclic vomiting syndrome(0.48%) and rumination syndrome(0.18%) were rare. The most common FGIDs in children/adolescents were functional dyspepsia(58.98%),followed by functional constipation(21.17%),irritable bowel syndrome(9.25%),functional nausea/vomiting(6.05%),cyclic vomiting syndrome(1.78%) and functional abdominal pain-NOS(1.51%). However,aerophagia(0.45%),ruminantion syndrome(0.09%),abdominal migraine(0.35%) and nonretentive fecal incontinence(0.35%) were rare. A total of 56(3.37%,56/1664) patients with neonate/toddlers FGIDs had an overlap of diseases,mainly infant nausea(G1),infant abdominal colic(G4) and infant defecation difficulty(G7). Seventy-eight patients(6.93%,78/1124) with children/adolescents FGIDs had comorbidity,mainly cyclic vomiting syndrome,functional nausea/vomiting,functional dyspepsia,abdominal migraine,and functional constipation. Conclusion About 1/4 of the patients in pediatric gastroenterology clinics are FGIDs,which is more common in children/adolescents. Some FGIDs are correlated with age and gender. There is an overlap in the diagnosis of FGIDs in children. Clinical pediatricians should pay attention to the diagnosis and treatment of children’s FGIDs to avoid misdiagnosis,mistreatment and overtreatment.
    Bartters syndrome caused by CLCNKB gene mutation:A report of one case and literature review
    LIU Yong-lin,LIU Rui,Bilal Haider Shamsi
    2021, 36(8): 637-640.  DOI: 10.19538/j.ek2021080616
    Abstract ( )